RARE vs CPRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 02, 2026
RARE
CPRX
Investment Advisor Scores
CPRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | RARE | CPRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 12.9534 | Tie |
| PEG Ratio | -0.24 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -2.2% | 5.6% | CPRX |
| Earnings Growth | 0.0% | 11.1% | CPRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.3/100 | 58.5/100 | CPRX |
| Profit Margin | -90.9% | 37.1% | CPRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
RARE
NeutralMixed signals - no dominant trend phase, RSI 34
CPRX
MarkupPrice above SMA50, rising 50-day trend (6.9% over 20 days), RSI 71
Fundamentals Snapshot
| Metric | RARE | CPRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.0 | 9.9 |
| Trailing P/E | — | 18.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | -0.3% | 0.8% |
| Operating Margin | -1.0% | 0.5% |
| EPS | -6.35 | 1.73 |
| Dividend Yield | — | — |